Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease

BACKGROUND/AIMS: Infliximab (IFX) often loses its therapeutic effect in initial responders with inflammatory bowel disease (IBD) over time. Low serum IFX trough levels (TLs) are linked to poor clinical response and outcomes. Maintenance of optimal therapeutic IFX concentrations is important for sust...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Gut Liver
Päätekijät: Choi, So Yoon, Kang, Ben, Choe, Yon Ho
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Editorial Office of Gut and Liver 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6743797/
https://ncbi.nlm.nih.gov/pubmed/30970435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl18129
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia